share_log

OptimizeRx Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results and Issued FY24 Sales Guidance Below Estimates.

OptimizeRx Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results and Issued FY24 Sales Guidance Below Estimates.

optimizerx股价下跌,公司报告称Q3销售业绩不佳,并发布FY24销售指引低于预期。
Benzinga ·  2024/11/14 05:35

OptimizeRx Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results and Issued FY24 Sales Guidance Below Estimates.

优化药品的股票在公司报告了低于预期的第三季度销售业绩并发布了低于预估的2024财年销售指引后交易下跌。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发